The Use of Platelet Rich Plasma in the Treatment of Degenerative Joint Disease in Cats: An Exploratory Case Series

Regenerative Medicine

The Use of Platelet Rich Plasma in the Treatment of Degenerative Joint Disease in Cats: An Exploratory Case Series

  • July 12 2024
  • Lisa A. Miller, DVM, CCRT
The Use of Platelet Rich Plasma in the Treatment of Degenerative Joint Disease in Cats: An Exploratory Case Series
1:08

LINK TO FULL STUDY

Authors: Janice Huntingford1 Andrea Looney2 James Johnson3  Lisa Miller3*
1Essex Animal Hospital, Essex, ON, Canada
2Central Hospital for Veterinary Medicine, North Haven, CT, United States
3Companion Animal Health, New Castle, DE, United States

 

Objective: To evaluate the effectiveness of intra-articular autologous Platelet Rich Plasma (PRP) in managing Degenerative Joint Disease (DJD) in cats.

Design: Prospective pilot clinical trial.

Methods: Six domestic cats with clinically and radiographically diagnosed DJD received intra-articular injections of autologous PRP. Clinical assessments pre and post intra-articular injections were conducted using the Feline Musculoskeletal Pain Index (FMPI, owner assessed) and Visual Analog Scale (VAS, clinician assessed) at baseline, Day 14, Day 28, and Day 42–45

Results: Significant improvements were noted in both FMPI and VAS scores at the end of the study period, indicating enhanced joint function and reduced pain.

Conclusion and clinical relevance: The study suggests the potential of PRP therapy as a safe and effective treatment for feline DJD, warranting further research with larger cohorts and longer follow-up to establish comprehensive treatment guidelines.